Animal models of anxiety: an ethological perspective - PubMed (original) (raw)
Review
Animal models of anxiety: an ethological perspective
R J Rodgers et al. Braz J Med Biol Res. 1997 Mar.
Abstract
In the field of anxiety research, animal models are used as screening tools in the search for compounds with therapeutic potential and as simulations for research on mechanism underlying emotional behaviour. However, a solely pharmacological approach to the validation of such tests has resulted in distinct problems with their applicability to systems other than those involving the benzodiazepine/GABAA receptor complex. In this context, recent developments in our understanding of mammalian defensive behaviour have not only prompted the development of new models but also attempts to refine existing ones. The present review focuses on the application of ethological techniques to one of the most widely used animal models of anxiety, the elevated plus-maze paradigm. This fresh approach to an established test has revealed a hitherto unrecognized multidimensionality to plus-maze behaviour and, as it yields comprehensive behavioural profiles, has many advantages over conventional methodology. This assertion is supported by reference to recent work on the effects of diverse manipulations including psychosocial stress, benzodiazepines, GABA receptor ligands, neurosteroids, 5-HT1A receptor ligands, and panicolytic/panicogenic agents. On the basis of this review, it is suggested that other models of anxiety may well benefit from greater attention to behavioural detail.
Similar articles
- Anxiolytic-like effect of 5-HT(2) ligands and benzodiazepines co-administration: comparison of two animal models of anxiety (the four-plate test and the elevated plus maze).
Massé F, Nic Dhonnchadha BA, Hascoët M, Bourin M. Massé F, et al. Behav Brain Res. 2007 Feb 27;177(2):214-26. doi: 10.1016/j.bbr.2006.11.031. Epub 2006 Dec 15. Behav Brain Res. 2007. PMID: 17175036 - Ethopharmacological analysis of the unstable elevated exposed plus maze, a novel model of extreme anxiety: predictive validity and sensitivity to anxiogenic agents.
Jones N, Duxon MS, King SM. Jones N, et al. Psychopharmacology (Berl). 2002 May;161(3):314-23. doi: 10.1007/s00213-002-1029-y. Epub 2002 Apr 5. Psychopharmacology (Berl). 2002. PMID: 12021835 - Animal models of 'anxiety': where next?
Rodgers RJ. Rodgers RJ. Behav Pharmacol. 1997 Nov;8(6-7):477-96; discussion 497-504. doi: 10.1097/00008877-199711000-00003. Behav Pharmacol. 1997. PMID: 9832964 Review. - Implication of the 5-HT2A and 5-HT2C (but not 5HT1A) receptors located within the periaqueductal gray in the elevated plus-maze test-retest paradigm in mice.
Gomes KS, Nunes-De-Souza RL. Gomes KS, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Oct 1;33(7):1261-9. doi: 10.1016/j.pnpbp.2009.07.015. Epub 2009 Jul 19. Prog Neuropsychopharmacol Biol Psychiatry. 2009. PMID: 19625008 - The test retest model of anxiety: An appraisal of findings to explain benzodiazepine tolerance.
Bourin M. Bourin M. Pharmacol Biochem Behav. 2019 Mar;178:39-41. doi: 10.1016/j.pbb.2017.12.009. Epub 2018 Jan 2. Pharmacol Biochem Behav. 2019. PMID: 29305159 Review.
Cited by
- Effects of morning compared with evening bright light administration to ameliorate short-photoperiod induced depression- and anxiety-like behaviors in a diurnal rodent model.
Krivisky K, Einat H, Kronfeld-Schor N. Krivisky K, et al. J Neural Transm (Vienna). 2012 Oct;119(10):1241-8. doi: 10.1007/s00702-012-0783-1. Epub 2012 Mar 13. J Neural Transm (Vienna). 2012. PMID: 22407379 - Imepitoin Shows Benzodiazepine-Like Effects in Models of Anxiety.
Engel O, Masic A, Landsberg G, Brooks M, Mills DS, Rundfeldt C. Engel O, et al. Front Pharmacol. 2018 Nov 1;9:1225. doi: 10.3389/fphar.2018.01225. eCollection 2018. Front Pharmacol. 2018. PMID: 30455643 Free PMC article. - Differential Impact of Ad Libitum or Intermittent High-Fat Diets on Bingeing Ethanol-Mediated Behaviors.
Del Olmo N, Blanco-Gandía MC, Mateos-García A, Del Rio D, Miñarro J, Ruiz-Gayo M, Rodríguez-Arias M. Del Olmo N, et al. Nutrients. 2019 Sep 19;11(9):2253. doi: 10.3390/nu11092253. Nutrients. 2019. PMID: 31546853 Free PMC article. - Vicarious trial and error.
Redish AD. Redish AD. Nat Rev Neurosci. 2016 Mar;17(3):147-59. doi: 10.1038/nrn.2015.30. Nat Rev Neurosci. 2016. PMID: 26891625 Free PMC article. Review. - Cholecystokinin B receptor antagonists for the treatment of depression via blocking long-term potentiation in the basolateral amygdala.
Zhang X, Asim M, Fang W, Md Monir H, Wang H, Kim K, Feng H, Wang S, Gao Q, Lai Y, He J. Zhang X, et al. Mol Psychiatry. 2023 Aug;28(8):3459-3474. doi: 10.1038/s41380-023-02127-7. Epub 2023 Jun 26. Mol Psychiatry. 2023. PMID: 37365241
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical